Skip to main content

Rosenman Herm

In the past year, 2 open-market sale filings worth $15.1M and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$15.1M
2 filings
Net
−$15.1M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Rosenman Herm as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

NTRA Natera, Inc.

Director4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 26, 2026 (view filing)Jun 242 daysRosenman HermDirectorSSale−16.5K$250.00−$4.13M−79.5%4.25K after10b5-1
Dec 16, 2025 (view filing)Dec 124 daysRosenman HermDirectorSSale−48.4K$227.42−$11.0M−70.4%20.3K after4 lots
Feb 16, 2024 (view filing)Feb 16Same dayRosenman HermDirectorSSale−93.9K$69.37−$6.51M−60.4%61.7K after2 lots
Nov 9, 2021 (view filing)Nov 81 dayRosenman HermDirectorSSale−44.5K$117.39−$5.22M−46.5%51.3K afterAmended4 lots

DMTK DermTech, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 31, 2022 (view filing)May 922 daysRosenman HermDirectorPPurchase+20.0K$6.86+$137.2K+38.2%72.4K afterAmended